RxDoctor Payments Data

Stephen Karem

Family Medicine · Floyds Knobs, INNPI 1295719664

Payments from drug & device makers

$2,517in general payments, 2019–2025

Across 161 payments — averaging $15.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$370
  • Pfizer$304
  • Amgen$259
  • Biohaven Pharmaceuticals, Inc.$227
  • Boston Scientific$168
  • Axsome Therapeutics, Inc.$148
  • plus $1K from 21 others

What the payments were for

  • Food & beverage$2,509100%
  • Education$80%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,517 in reported general payments places this provider in the 75th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide15$19,883
EliquisApixaban17$17,167
Repatha SureclickEvolocumab24$16,814
JardianceEmpagliflozin14$12,123
OzempicSemaglutide11$9,047
Celecoxib26$1,816
SynthroidLevothyroxine Sodium11$1,493
Gabapentin35$963
Escitalopram Oxalate52$873
Trazodone Hcl53$782
Atorvastatin Calcium60$740
Ezetimibe25$721
Rosuvastatin Calcium68$675
ValacyclovirValacyclovir Hcl14$637
Famotidine30$630

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$84$19,88315 claims
PfizerEliquis$304$17,16717 claims
Boehringer IngelheimJardiance$27$12,12314 claims
Novo NordiskOzempic$141$9,04711 claims
AbbVieSynthroid$370$1,49311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Floyds Knobs

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →